Illumina, Avantome, Roche, 454 Life Sciences, Applied Biosystems, InteRNA Genomics, Biotique Systems, Genomatix Software, BioTeam, Invitrogen, Active Motif, Genetic Technologies, LabCorp, 23andMe, Oxford Biomedical Research Centre, International Genomics | GenomeWeb
Illumina to Acquire Sequencing Startup Avantome for up to $60M

Illumina said this week that it will acquire Avantome, a start-up company developing a low-cost, long-read sequencing technology that Illumina said will complement its Genome Analyzer platform.

As part of the deal, Illumina will make an up-front payment of $25 million and contingent payments of up to $35 million.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.